Policy UpdatesMedicaidApril 3, 2025

Clinical Criteria updates

Effective July 7, 2025

Summary: The Pharmacy and Therapeutics (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. For questions or additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements; new document number

Please share this notice with other members of your practice and office staff.

Please note:

  • The Clinical Criteria listed below apply only to the medical drug benefits contained within the member’s medical plan. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that have been adopted by the health plan only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective Date

Clinical Criteria Number

Clinical Criteria Title

Status

July 7, 2025

CC-0274

Bizengri (zenocutuzumab-zbco)

New

July 7, 2025

CC-0275

Ziihera (zanidatamab-hrii)

New

July 7, 2025

CC-0276

Tryngolza (olezarsen)

New

July 7, 2025

CC-0072

Vascular Endothelial Growth Factor (VEGF) Inhibitors

Revised

July 7, 2025

CC-0185

Oxlumo (lumasiran)

Revised

July 7, 2025

CC-0198

Relizorb (immobilized lipase) cartridge

Revised

July 7, 2025

CC-0256

Rivfloza (nedosiran)

Revised

July 7, 2025

CC-0042

Monoclonal Antibodies to Interleukin-17

Revised

July 7, 2025

CC-0063

Ustekinumab Agents (Stelara, Selarsdi, Imuldosa, Pyzchiva, Otulfi, Wezlana, Yesintek)

Revised

July 7, 2025

CC-0058

Bynfezia Pen, Sandostatin, or Sandostatin LAR (Octreotide) / Octreotide Agents

Revised

July 7, 2025

CC-0130

Imfinzi (durvalumab)

Revised

July 7, 2025

CC-0094

Pemetrexed

Revised

July 7, 2025

CC-0078

Orencia (abatacept)

Revised

Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross and Blue Cross of California Partnership Plan, Inc. are independent licensees of the Blue Cross Association. Blue Cross of California is contracted with L.A. Care Health Plan to provide Medi-Cal Managed Care services in Los Angeles County. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

CABC-CD-079041-25-CPN78054

PUBLICATIONS: May 2025 Provider Newsletter